JOHNSON & JOHNSON COMPLETES ACQUISITION OF PENINSULA

Johnson & Johnson announced that its Ortho-McNeil Pharmaceutical subsidiary completed its planned acquisition of Peninsula Pharmaceuticals, a privately-held biopharmaceutical company focused on developing and commercializing antibiotics to treat life-threatening infections. The transaction was announced previously on April 19, 2005.

DrugNewswire (http://www.drugnewswire.com/885/)